Results 311 to 320 of about 22,453,438 (395)
Low-dose Interleukin-2 Therapy: Fine-tuning Treg in Solid Organ Transplantation? [PDF]
Amini L, Kaeda J, Weber O, Reinke P.
europepmc +1 more source
S‐ketamine binds directly to SIRT2, facilitating its interaction with NF‐κB p65. This interaction reduces the acetylation of NF‐κB p65 and inhibits its activation, thereby exerting anti‐inflammatory and antidepressant effects. Created by BioRender.
Cong Lin+7 more
wiley +1 more source
A CD25-biased interleukin-2 for autoimmune therapy engineered via a semi-synthetic organism. [PDF]
Ptacin JL+23 more
europepmc +1 more source
Engineered Probiotics Mitigate Gut Barrier Dysfunction Induced by Nanoplastics
Intestinal barrier stability is vital for gut health. Plastic polyethylene terephthalate (PET) disrupts this barrier, causing inflammation and infections. This study encodes transforming growth factor‐β into EcN and modifies its surface with pH‐responsive polymer (EcNT@L), creating an oral drug delivery system to repair nano PET‐induced intestinal ...
Wenxin Chen+9 more
wiley +1 more source
A Precision Engineered Interleukin-2 for Bolstering CD8+ T- and NK-cell Activity without Eosinophilia and Vascular Leak Syndrome in Nonhuman Primates. [PDF]
Ma L+22 more
europepmc +1 more source
The impact of topography on the secretome of adipose‐derived stem cells (ADSCs) has the potential for promoting tendon regeneration. The secretome generated from ADSCs on aligned structure has a potent effect in promoting cell migration, proliferation, tenogenic differentiation, macrophage M2 polarization, and tendon mechanical function recovery ...
Qiuzi Long+14 more
wiley +1 more source
Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases. [PDF]
Tomasovic LM+4 more
europepmc +1 more source
This study presents decursin, a traditional Chinese medicine monomer, that inhibits lipid accumulation and inflammation in atherosclerosis through PKCδ interaction. A novel targeted delivery system (ALD@EM) is developed to overcome decursin's short half‐life, combining antibody‐mediated targeting, LDL‐facilitated chemotaxis, and enhanced macrophage ...
Hui Chen+13 more
wiley +1 more source
A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic. [PDF]
Beig Parikhani A+9 more
europepmc +1 more source